Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dutton report should be of no concern...

"One of the principal goals of our business plan is to get our stock listed on a national exchange as soon as possible, although that remains dependent on our share price moving to a significantly higher plateau."

I sure hope we do it the old-fashioned way...we EARN IT ..and not RS it

"In the months of July through November 2006, management implemented a share repurchase plan as authorized and publicly announced by the Board of Directors and reported in our last quarterly filing. We continued to purchase shares during the months of December 2006 and January 2007. The Board of Directors and management believed that our stock was undervalued in the market and that it was a prudent use of corporate funds for Patriot Scientific Corporation to purchase more of its shares. As of this writing we have purchased over 10 million shares of Patriot Scientific Corporation common stock in the open market. Future buybacks will depend upon market conditions and prudent asset and financial management considerations."

I assume that means there was no repurchases after January up till this was written a few days ago. If so, they need to get back on that bandwagon soon esp. if they have confidence in the Markman while shares are lower than they should/will be.

LMHO

Share
New Message
Please login to post a reply